Middle East and Africa Anaphylaxis Treatment Market is expected to reach US$ 87.1 Mn by 2028

Epinephrine Segment has the Largest Share of Medication Type in the Middle East and Africa Anaphylaxis Treatment Market during 2021–2028

According to a new market research study on “Middle East and Africa Anaphylaxis Treatment Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Medication Type, Route of Administration, Allergy Type, and Distribution Channel,” is expected to reach US$ 87.1 million by 2028 from US$ 52.2 million in 2021. The market is estimated to grow at a CAGR of 7.6% from 2021 to 2028. The report provides trends prevailing in the Middle East and Africa anaphylaxis treatment market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the rising incidence of anaphylaxis and recent approvals of epinephrine are the key factors driving the market growth. However, the market is expected experiencing slow growth during the forecast period owing to the poor accessibility to epinephrine auto-injectors in low-income countries.

Countries in the Middle East have also widely affected the socio-economic condition by the COVID–19 pandemic. However, the countries have wisely reacted to the COVID–19 pandemic to avoid the spread of infection. Similar to other regions, lockdown and social distancing were imposed, which has impaired these trends hindering access to work, regular income, payments, fairs, schools, and healthcare. Therefore, it is expected the countries have undergone huge losses and are still trying to recover them. Due to the less developed economies majority of the countries are depended on the suppliers of medical devices. In addition, there is high uncertainty of the spread of COVID-19 in Africa and other low-income countries such as Cameroon, Egypt, Algeria, Morocco, South Africa, Togo, Nigeria, Senegal, and Tunisia. Due to a widespread outbreak of COVID-19 in Africa, has led to disruption in healthcare services. However, the anaphylaxis treatment market in this pandemic is growing due to the increasing awareness about treatments of asthma and allergic diseases linked to viral infection in the region.

The market for anaphylaxis treatment market is segmented into medication type, route of administration, allergy type, and distribution channel. Based on medication type, the anaphylaxis treatment market is segmented epinephrine, antihistamines, steroids, beta-agonist, and others. In 2020, epinephrine segment accounted for the highest share of the market. The growth of the epinephrine is attributed due to easy access to the epinephrine, rising incidences of allergic reactions and growing government policies to access epinephrine to school-going children. Additionally, the rise in the number of a product launch for generic version epinephrine is key factor responsible for the growth of the market. For instance, in July 2019, Sandoz, a Novartis AG division, has launched its generic pre-filled Symjepi epinephrine shots across the country.

Amneal Pharmaceuticals Inc., Mylan N.V., Abbott, Pfizer Inc., Glaxosmithkline Plc., Merck and Co., Inc., Teva Pharmaceutical Industries Ltd., and ALK-ABELLó are among the leading companies in the Middle East and Africa anaphylaxis treatment market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in December 2020, GSK Consumer Healthcare launched Otrivin Breathe clean, a saline wash with the moisturizing benefit of natural glycerin. The daily usage of the nasal spray washes out the allergens, pollutants, and debris that are trapped in the nasal passage, helping in the removal of allergy symptoms, and thus maintaining nasal hygiene. 

The report segments the Middle East and Africa Anaphylaxis Treatment market as follows:

By Medication Type

• Epinephrine
• Antihistamines
• Steroids
• Beta-Agonist
• Others

By Route of Administration

• Parenteral
• Oral
• Others

By Allergy Type

• Food Allergy
• Medications
• Insect Stings
• Others

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Others

By Country

• Middle East and Africa
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of Middle East and Africa